Cipher Pharmaceuticals Inc. (TSX:CPH)

Cipher Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	384	366	133	96	46	25
Market Cap Growth	15.41%	175.35%	37.94%	107.72%	84.74%	-37.88%
Enterprise Value	391	409	77	59	27	23
Last Close Price	15.20	14.32	5.54	3.84	1.77	0.93
PE Ratio	16.31	22.06	4.94	2.68	4.73	4.34
Forward PE	14.62	15.93	11.11	8.77	3.95	4.53
PS Ratio	5.51	7.63	4.76	3.45	1.67	0.91
PB Ratio	2.42	2.49	1.25	1.11	0.94	0.60
P/TBV Ratio	12.08	41.47	1.60	1.56	1.88	1.55
P/FCF Ratio	9.24	-	6.36	6.70	2.66	1.69
P/OCF Ratio	9.23	13.03	6.30	6.65	2.66	1.69
EV/Sales Ratio	5.61	8.51	2.74	2.12	0.96	0.85
EV/EBITDA Ratio	14.25	24.29	5.07	3.67	1.54	1.39
EV/EBIT Ratio	21.99	36.19	5.63	3.97	1.62	1.51
EV/FCF Ratio	9.40	-	3.66	4.12	1.53	1.58
Debt / Equity Ratio	0.12	0.40	0.00	0.01	0.01	0.06
Debt / EBITDA Ratio	0.68	3.42	0.03	0.04	0.04	0.14
Debt / FCF Ratio	0.45	-	0.02	0.04	0.04	0.16
Net Debt / Equity Ratio	0.04	0.22	-0.49	-0.44	-0.51	-0.22
Net Debt / EBITDA Ratio	0.25	1.95	-3.45	-2.38	-1.47	-0.55
Net Debt / FCF Ratio	0.17	-0.38	-2.49	-2.67	-1.45	-0.62
Asset Turnover	0.33	0.27	0.27	0.33	0.46	0.48
Inventory Turnover	2.15	2.11	1.59	2.10	2.90	3.16
Quick Ratio	0.91	1.60	8.55	3.80	2.21	1.85
Current Ratio	1.31	1.94	9.19	4.07	2.38	2.03
Return on Equity (ROE)	16.32%	12.63%	28.19%	51.73%	21.69%	14.46%
Return on Assets (ROA)	5.30%	3.95%	8.06%	11.01%	17.02%	16.76%
Return on Invested Capital (ROIC)	10.54%	9.45%	26.86%	40.52%	41.44%	28.85%
Return on Capital Employed (ROCE)	10.10%	5.50%	12.80%	17.20%	33.20%	35.40%
Earnings Yield	6.29%	4.53%	20.23%	37.37%	21.14%	23.05%
FCF Yield	10.83%	-23.75%	15.73%	14.93%	37.64%	59.20%
Buyback Yield / Dilution	-4.82%	0.79%	1.46%	3.84%	1.96%	-1.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.